Skip to main content

Table 2 Participant responses to pharmacogenomic test statements

From: Precision medicine from a citizen perspective: a survey of public attitudes towards pharmacogenomics in Flanders

  Completely disagree
N(%)
Disagree
N(%)
Neutral
N(%)
Agree
N(%)
Completely agree
N(%)
Pharmacogenomic tests could help improve health care 0 (0.0%) 0 (0.0%) 20 (12.8%) 88 (56.4%) 48 (30.8%)
Pharmacogenomic tests could be an important aid during health care research 1 (0.6%) 1 (0.6%) 8 (5.1%) 86 (55.1%) 60 (38.5%)
I would feel more at ease taking a drug if pharmacogenomic tests have proved the drug is safe and effective for me 1 (0.6%) 4 (2.6%) 26 (16.7%) 72 (46.2%) 53 (34,0%)
I would improve my medication-adherence if pharmacogenomic tests have proved the drug is safe and effective for me 3 (1.9%) 26 (16.7%) 54 (34.6%) 43 (27.6%) 30 (19.2%)
I would worry about my privacy if my genetic data is saved in my central medical record 33 (21.2%) 61 (39.1%) 38 (24.4%) 18 (11.5.5%) 6 (3.8%)
I would prefer it if all my genetic factors are analysed in one test, making more information available, than having only the parts of my genetics analysed that could be relevant for my drugs 8 (5.1%) 16 (10.3%) 32 (20.5%) 65 (41.7%) 35 (22.4%)
I would like to limit the amount of health care practitioners that have access to my test results 8 (5.1%) 31 (19.9%) 42 (26.9%) 47 (30.1%) 28 (17.9%)
I would like a direct availability of my test results for my health care practitioners 4 (2.6%) 15 (9.6%) 29 (18.6%) 88 (56.4%) 20 (12.8%)
I would be willing to pay €100 for a pharmacogenomic test 11 (7.1%) 38 (24.4%) 53 (34.0%) 41 (26.3%) 11 (7.1%)
I would be willing to take a pharmacogenomic test if this was partially reimbursed 4 (2.6%) 5 (3.2%) 28 (17.9%) 86 (55.1%) 33 (21.2%)
I would be willing to take a pharmacogenomic test if this was completely reimbursed 1 (0.6%) 3 (1.9%) 13 (8.3%) 60 (38.5%) 79 (50.6%)